ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T) JPX

Currency In JPY

AD

Valuation

Market Cap66.99B
Enterprise Value68.29B
P/E Ratio12.22
PEG Ratio-1.7
Price/Sales Ratio0.81
Price/Book Ratio0.81
Enterprise/Revenue0.88
Enterprise/EBITDA9.32

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.07
Operating Margin0.07
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.07

Income Statement

Revenue71.13B
Revenue/Share2,495.76
Gross Profit34.15B
EBITDA8.75B
Net Income5.43B
Diluted EPS191.1

Balance Sheet

Total Cash7.11B
Total Cash/Share250.32
Total Debt11.84B
Total Debt/Equity0.17
Current Ratio2.89
Book Value Per Share2,722.03

Price History

52-Week Change-7.73
52-Week High3,045
52-Week Low1,917
Moving Average 50 Days2,091.38
Moving Average 200 Days2,362.38

Statistics

Average Volume73,878
Shares Outstanding28.4M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate65
Trailing Annual Dividend Yield3.2
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD